Practice Management News

BOSTON — Pangenotypic NS5A inhibitor GS-5816 in combination with sofosbuvir-containing regimens demonstrated encouraging results in a number of patient cohorts, according to findings presented here.

Treatment with polyethylene glycol 3350-electrolyte solution, or PEG, improved overt hepatic encephalopathy among patients with cirrhosis faster vs. standard of care treatment with lactulose, according to recent study data.   

Researchers have successfully analyzed “Big Data,” in this case, enormous amounts of details from electronic health records, to gain accurate insights into patients’ conditions and predict diseases.

BOSTON — Liver transplant recipients with hepatitis C virus infection genotype 1 achieved sustained virologic response after 12 weeks of therapy with a regimen of three direct-acting antivirals, with ribavirin, according to data presented at The Liver Meeting.

BOSTON — A number of patients with hepatitis C virus genotype 1 infection, with and without cirrhosis, and patients coinfected with HIV and HCV, achieved sustained virologic response at 12 weeks when treated with grazoprevir and elbasvir, with or without ribavirin, according to data from the phase 2 trial of the C-WORTHY study presented at The Liver Meeting.

BOSTON — A fixed-dose combination involving the novel compound BMS-791325 was associated with SVR12 rates of around 90% in treatment-naive and experienced patients, according to findings from the UNITY trials series presented here.

BOSTON — Hepatitis B virus is common among US veterans, but new data indicate that rates of serologic testing and adherence to treatment guidelines in this patient population are low.

BOSTON — Management of hepatitis C virus before and after transplantation varies in the United States, according to results of a survey of medical directors at US liver transplant programs.

The American Medical Association announced it has issued a letter to CMS expressing concern over the effect of Medicare incentive programs on physicians and their practices.

Hospitals that converted to a for-profit model showed financial improvements but no changes in outcomes, according to a new investigation.